April 11, 2016 / Author: / Reviewed by: Beth Bolt, RPh
(RxWiki News) The US Preventive Services Task Force (USPSTF) just released new guidance on daily aspirin to prevent cardiovascular disease (CVD) and colorectal cancer. But what was behind that recommendation?
Three large, systematic evidence reviews and a modeling paper, as it turns out. That means three studies, conducted on behalf of the USPSTF and published in the Annals of Internal Medicine, looked back at other studies on aspirin’s role in CVD and colorectal cancer prevention and found that it could lower those risks for some patients.
But these reviews also confirmed some past findings on daily aspirin’s role in gastrointestinal bleeding risk, a potentially deadly complication.
To clarify these findings, the USPSTF conducted a study that modeled the risks and benefits of daily aspirin use. Here’s what the task force found:
In the end, though, even the USPSTF says the decision on whether to take a daily aspirin should come down to individual doctor and patient preferences.